Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Radiation Oncology
Published in: Journal of Radiation Oncology 3/2018

01-09-2018 | Obituary

In memoriam: the legendary Dr. Luther Brady—founding ACRO president and founding JRO editor in chief

Authors: Bin S. Teh, James S. Welsh, Jiade J. Lu

Published in: Journal of Radiation Oncology | Issue 3/2018

Login to get access

Excerpt

This special issue of the Journal of Radiation Oncology is dedicated to our founding Editor-in-Chief, the late Dr. Luther Brady. Dr. Brady passed away recently, leaving behind a truly remarkable legacy in the field of radiation oncology. Across the world, countless colleagues and mentees will remember him as a great person and fantastic mentor who made an astonishing number of significant contributions to our specialty. …
Metadata
Title
In memoriam: the legendary Dr. Luther Brady—founding ACRO president and founding JRO editor in chief
Authors
Bin S. Teh
James S. Welsh
Jiade J. Lu
Publication date
01-09-2018
Publisher
Springer Berlin Heidelberg
Published in
Journal of Radiation Oncology / Issue 3/2018
Print ISSN: 1948-7894
Electronic ISSN: 1948-7908
DOI
https://doi.org/10.1007/s13566-018-0360-9

Other articles of this Issue 3/2018

Journal of Radiation Oncology 3/2018 Go to the issue

Original Research

Tolerability of sequential immune therapy and palliative radiotherapy to the cervical and thoracic spine

Original Research

A comprehensive analysis of clinical trials including both immunotherapy and radiation therapy

Original Research

Reducing radiation dermatitis during ongoing radiation therapy: an innovative film-forming wound dressing

Original Research

A fiducial-less tracking method for radiation therapy of liver tumors by diaphragm disparity analysis part 1: simulation study using machine learning through artificial neural network

Original Research

The effects of treatment duration on outcomes of radiation treatment with high-dose-rate brachytherapy in the era of concurrent chemoradiation for cervical carcinoma

Original Research

Stereotactic radiosurgery practice patterns for brain metastases in the United States: a national survey
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits